Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Hougaard

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Statistics in Medicine|March 10, 2010
PrefacePhilip Hougaard
Lifetime Data Analysis|August 15, 2022
Choice of time scale for analysis of recurrent events dataPhilip Hougaard
Statistics in Medicine|December 10, 2014
Guest editors' introduction. PrefaceTim Friede, Robin Henderson, Philip Hougaard
Diabetes Care|April 30, 2002
Risk factors for development of incipient and overt diabetic nephropathy in type 1 diabetic patients: a 10-year prospective observational studyPeter Rossing, Philip Hougaard, Hans-Henrik Parving
Kidney International|September 17, 2005
Progression of microalbuminuria in type 1 diabetes: ten-year prospective observational studyPeter Rossing, Philip Hougaard, Hans-Henrik Parving
Pharmaceutical Statistics|August 14, 2024
Principles for Defining Estimands in Clinical Trials-A ProposalTobias Mütze, James Bell, Stefan Englert, et al.
Genes|February 23, 2019
Lifespans of Twins: Does Zygosity Matter?Jacob Hjelmborg, Pia Larsen, Jaakko Kaprio, et al.
Plos One|November 23, 2017
Is there a reasonable excuse for not providing post-operative analgesia when using animal models of peripheral neuropathic pain for research purposes?Sara Hestehave, Gordon Munro, Rie Christensen, et al.
Journal of Diabetes and Its Complications|May 18, 2004
The significance of the prepubertal diabetes duration for the development of retinopathy and nephropathy in patients with type 1 diabetesBirthe S Olsen, Anne Katrin Sjølie, Philip Hougaard, et al.
Non-Coding RNA|November 25, 2018
Influence of Disease Duration on Circulating Levels of miRNAs in Children and Adolescents with New Onset Type 1 DiabetesNasim Samandari, Aashiq H Mirza, Simranjeet Kaur, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Statistics in Medicine|March 10, 2010
PrefacePhilip Hougaard
Lifetime Data Analysis|August 15, 2022
Choice of time scale for analysis of recurrent events dataPhilip Hougaard
Statistics in Medicine|December 10, 2014
Guest editors' introduction. PrefaceTim Friede, Robin Henderson, Philip Hougaard
Diabetes Care|April 30, 2002
Risk factors for development of incipient and overt diabetic nephropathy in type 1 diabetic patients: a 10-year prospective observational studyPeter Rossing, Philip Hougaard, Hans-Henrik Parving
Kidney International|September 17, 2005
Progression of microalbuminuria in type 1 diabetes: ten-year prospective observational studyPeter Rossing, Philip Hougaard, Hans-Henrik Parving
Pharmaceutical Statistics|August 14, 2024
Principles for Defining Estimands in Clinical Trials-A ProposalTobias Mütze, James Bell, Stefan Englert, et al.
Genes|February 23, 2019
Lifespans of Twins: Does Zygosity Matter?Jacob Hjelmborg, Pia Larsen, Jaakko Kaprio, et al.
Plos One|November 23, 2017
Is there a reasonable excuse for not providing post-operative analgesia when using animal models of peripheral neuropathic pain for research purposes?Sara Hestehave, Gordon Munro, Rie Christensen, et al.
Journal of Diabetes and Its Complications|May 18, 2004
The significance of the prepubertal diabetes duration for the development of retinopathy and nephropathy in patients with type 1 diabetesBirthe S Olsen, Anne Katrin Sjølie, Philip Hougaard, et al.
Non-Coding RNA|November 25, 2018
Influence of Disease Duration on Circulating Levels of miRNAs in Children and Adolescents with New Onset Type 1 DiabetesNasim Samandari, Aashiq H Mirza, Simranjeet Kaur, et al.
Pageof 3